¥27.31
¥-0.10 (-0.36%)
End-of-day quote: 05/17/2024
SZSE:000403
Pacific Shuanglin Bio-pharmacy Co., LTD Annual Report
| Year | Year | 2023 | 2012 | 2020 | 2019 | 2018 | 2016 | ||
|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
¥2.33B | ¥469.82M | ¥1.05B | ¥915.66M | ¥859.84M | ¥561.21M | |
| GM % | Gross Margin % |
|
100.00% | 60.43% | 48.82% | 52.08% | 53.33% | 55.98% | |
| OM | Operating Margin |
|
29.85% | 32.06% | 21.58% | 20.84% | 13.66% | 13.98% | |
| EPS | Earnings Per Share |
|
¥0.00 | ¥0.73 | ¥0.38 | ¥0.29 | ¥0.14 | ¥0.11 | ¥0.14 |
| Div. | Dividends |
|
¥0.07 | ¥0.00 | ¥0.00 | ¥0.07 | ¥0.00 | ¥0.00 | |
| PR % | Payout Ratio % |
|
9.59% | 0 | 0.00% | 24.14% | 0 | 0 | |
| Sha. | Shares |
|
733m | 401.6m | 492.43m | 489.22m | 489.22m | 489.22m | |
| OCF | Operating Cash Flow |
|
¥0.00M | ¥123.24M | ¥194.84M | ¥190.84M | ¥116.63M | ¥62.49M | |
| FCF | Free Cash Flow |
|
¥0.00M | ¥-57.04M | ¥154.66M | ¥149.73M | ¥81.61M | ¥-35.54M | |
| FCFS | Free Cash Flow Per Share |
|
¥0.00 | ¥-0.12 | ¥0.32 | ¥0.31 | ¥0.17 | ¥-0.07 |
